Inogen Inc (NASDAQ:INGN) — Market Cap & Net Worth
Market Cap & Net Worth: Inogen Inc (INGN)
Inogen Inc (NASDAQ:INGN) has a market capitalization of $174.63 Million ($174.63 Million) as of August 3, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #17013 globally and #3980 in its home market, demonstrating a 2.06% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Inogen Inc's stock price $6.45 by its total outstanding shares 27074516 (27.07 Million). See INGN capex to operating cash flow ratio to understand how much of operating cash flow is reinvested back into capital assets.
Inogen Inc Market Cap History: 2015 to 2026
Inogen Inc's market capitalization history from 2015 to 2026. Data shows change from $1.09 Billion to $174.63 Million (-16.59% CAGR).
Index Memberships
Inogen Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.46 Trillion | 0.01% | #463 of 976 |
|
NASDAQ Composite
IXIC
|
$40.26 Trillion | 0.00% | #1670 of 3165 |
Weight: Inogen Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Inogen Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Inogen Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.52x
Inogen Inc's market cap is 0.52 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.82 Billion | $202.83 Million | $20.52 Million | 8.97x | 88.63x |
| 2017 | $3.22 Billion | $249.44 Million | $21.00 Million | 12.93x | 153.51x |
| 2018 | $3.36 Billion | $358.11 Million | $51.84 Million | 9.39x | 64.84x |
| 2019 | $1.85 Billion | $361.94 Million | $20.95 Million | 5.11x | 88.31x |
| 2020 | $1.21 Billion | $308.49 Million | -$5.83 Million | 3.92x | N/A |
| 2021 | $920.53 Million | $358.00 Million | -$6.33 Million | 2.57x | N/A |
| 2022 | $533.64 Million | $377.24 Million | -$83.77 Million | 1.41x | N/A |
| 2023 | $148.64 Million | $315.66 Million | -$102.45 Million | 0.47x | N/A |
| 2024 | $248.27 Million | $335.70 Million | -$35.89 Million | 0.74x | N/A |
| 2025 | $181.94 Million | $348.67 Million | -$22.75 Million | 0.52x | N/A |
Competitor Companies of INGN by Market Capitalization
Companies near Inogen Inc in the global market cap rankings as of August 3, 2026.
Key companies related to Inogen Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #114 globally with a market cap of $183.80 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #189 globally with a market cap of $124.64 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #233 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #238 globally with a market cap of $103.60 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #114 | Abbott Laboratories | NYSE:ABT | $183.80 Billion | $105.70 |
| #189 | Stryker Corporation | NYSE:SYK | $124.64 Billion | $325.70 |
| #233 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #238 | Medtronic PLC | NYSE:MDT | $103.60 Billion | $85.39 |
Inogen Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Inogen Inc's market cap moved from $1.09 Billion to $ 174.63 Million, with a yearly change of -16.59%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $174.63 Million | -4.02% |
| 2025 | $181.94 Million | -26.72% |
| 2024 | $248.27 Million | +67.03% |
| 2023 | $148.64 Million | -72.15% |
| 2022 | $533.64 Million | -42.03% |
| 2021 | $920.53 Million | -23.90% |
| 2020 | $1.21 Billion | -34.61% |
| 2019 | $1.85 Billion | -44.97% |
| 2018 | $3.36 Billion | +4.27% |
| 2017 | $3.22 Billion | +77.28% |
| 2016 | $1.82 Billion | +67.55% |
| 2015 | $1.09 Billion | -- |
End of Day Market Cap According to Different Sources
On Aug 3rd, 2026 the market cap of Inogen Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $174.63 Million USD |
| MoneyControl | $174.63 Million USD |
| MarketWatch | $174.63 Million USD |
| marketcap.company | $174.63 Million USD |
| Reuters | $174.63 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Inogen Inc
Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen the… Read more